Skip to main navigation Skip to search Skip to main content

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial

  • Salim Yusuf
  • , Kok Lay Teo
  • , Craig S Anderson
  • , J Pogue
  • , L Dyal
  • , I Copland
  • , H Schumacher
  • , G Dagenais
  • , P Sleight
  • , Christopher Bladin

Research output: Contribution to journalArticleResearchpeer-review

Original languageEnglish
Pages (from-to)1174 - 1183
Number of pages10
JournalThe Lancet
Volume372
Issue number9644
Publication statusPublished - 2008

Cite this